目的:研究斯皮诺素在大鼠胃、肠及各肠段的吸收动力学,为其剂型设计提供生物药剂学依据。方法:采用大鼠在体胃肠吸收模型,用高效液相色谱法测定胃肠灌注液中药物的浓度。结果:不同质量浓度(10,20,40 mg·L-1)的斯皮诺素在大鼠胃部2 h的吸收百分率分别为20.35%,21.88%,20.23%;药物在十二指肠、空肠、回肠、结肠的吸收速率常数为(0.026 4±0.001 4),(0.023 4±0.000 9),(0.022 6±0.000 9),(0.026 5±0.000 6)h-1;药物质量浓度为10,20,40 mg·L-1时,肠的吸收速率常数分别为(0.023 1±0.001 5),(0.024 1±0.001 6),(0.023 3±0.002 9)h-1;当pH为6.5,7.2,7.8时,肠的吸收速率常数分别为(0.023 5±0.001 5),(0.024 1±0.001 6),(0.022 1±0.002 6)h-1。结论:斯皮诺素在大鼠胃肠道各部分均有吸收,且吸收呈一级动力学过程,吸收机制为被动扩散;药物在大鼠肠内吸收不受药物浓度和pH的影响;药物的吸收按十二指肠、结肠、空肠、回肠的顺序依次下降,药物在胃中的吸收较好。
Objective: To investigate the absorption kinetics of spinosin in the gastrointestinal of rat, to provide the biological pharmaceutical basis for dosage design. Method: The absorption kinetics was investigated in rats using situ perfusion method. RP-HPLC was used to determine the concentrations of spinosin. Result: The absorption percentages at concentration of (10, 20, 40 m· L^-1) in stomach were 20.35%, 21.88%, 20.23% , respectively. The absorption rate constant (Ka)in duodenum, jejunum, ileum and colon were (0. 026 4 ± 0.001 4), (0. 023 4 ±0. 000 9), (0. 0226 ±0. 000 9), (0. 026 5 ±0. 000 6) h^-1, respectively. Intestinal Ka of spinosin at different concentrations ( 10, 20, 40 mg. L^-1 ) were (0. 023 1 ± 0. 001 5 ), (0. 024 1 ± 0. 001 6), (0. 023 3 ±0.002 9) h^-1, respectively. Ka at pH of 6.5, 7.2 and 7.8 for the whole intestine were (0. 023 5 ± 0.001 5), (0.024 1 ±0.001 6), (0.022 1 ±0.002 6) h^-1. Conclusion: Spinosin was absorbed in all segments in the pattern of first-order kinetics with the passive diffusion absorption mechanism; concentration and pH of the drug solution have no effect on the absorption kinetics; the absorption at duodenum, colon, jejunumand ileum align in a decreasing order. Spinosin was well absorbed at stomach.